A comparative study of the effects of anti-tumour and immunosuppressive drugs on antibody-forming and erythropoietic cells.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects* / Q000528:radiation effects; D000921:Antibody-Producing Cells / Q000187:drug effects / Q000528:radiation effects; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D003078:Colchicine / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004920:Erythropoiesis / Q000187:drug effects* / Q000528:radiation effects; D005260:Female; D006834:Hydrazines / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007503:Iron Isotopes; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008937:Mitomycins / Q000494:pharmacology; D011830:Radiation Effects; D013154:Spleen / Q000187:drug effects*; D014747:Vinblastine / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D006834:Hydrazines; D007166:Immunosuppressive Agents; D007503:Iron Isotopes; D008937:Mitomycins; D003609:Dactinomycin; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D003078:Colchicine; D008727:Methotrexate